Postherpetic polyneuropathy is a complication of herpes zoster (shingles) characterized by persistent nerve pain following the resolution of the rash. This condition arises from the reactivation of the varicella-zoster virus, leading to significant morbidity. Accurate coding with ICD-10 Code B02.23 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code B02.23 specifically denotes postherpetic polyneuropathy, a painful condition that can occur after an episode of shingles. This code should be used when documenting cases where patients experience neuropathic pain that persists beyond the acute phase of herpes zoster, facilitating accurate clinical documentation and appropriate billing for treatment and management.
Postherpetic polyneuropathy results from nerve damage caused by the varicella-zoster virus during a shingles outbreak. The condition can lead to chronic pain and sensory disturbances, necessitating medical intervention. Prompt diagnosis and treatment are crucial to alleviate symptoms and improve quality of life.
ICD-10 Code B02.23 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to postherpetic polyneuropathy. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and response to therapy.
In SOAP notes, ICD-10 Code B02.23 connects subjective patient-reported symptoms with objective clinical findings, facilitating a formal diagnosis of postherpetic polyneuropathy. This code supports continuity of care, aids in billing processes, and meets EHR documentation standards.
Postherpetic polyneuropathy requires prompt treatment to manage pain and improve patient outcomes. While not an infectious condition, effective management strategies are essential.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code B02.23 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
CPT Code | Description |
---|---|
99213 | Established patient office visit, level 3 |
96372 | Therapeutic, prophylactic, or diagnostic injection |
97001 | Physical therapy evaluation |
97530 | Therapeutic activities to improve functional performance |
Common Questions About Using ICD-10 Code B02.23 for Postherpetic polyneuropathy
What are the common symptoms of postherpetic polyneuropathy?
Common symptoms include persistent burning or stabbing pain in the affected area, tingling or numbness, and increased sensitivity to touch. These symptoms can significantly impact daily activities and quality of life.
How is postherpetic polyneuropathy diagnosed?
Diagnosis is typically based on the patient's history of shingles and the presence of persistent pain or sensory changes in the affected dermatome. Clinical examination and symptom assessment are crucial for accurate diagnosis.
What treatments are available for postherpetic polyneuropathy?
Treatment options include medications such as gabapentin or pregabalin for neuropathic pain, topical analgesics, and physical therapy. A multidisciplinary approach may be necessary for optimal management.
Is postherpetic polyneuropathy contagious?
No, postherpetic polyneuropathy is not contagious. It is a complication that arises from a previous herpes zoster infection, which can be contagious during the active rash phase but not after.
Clinical Notes
SOAP notes
DAP notes
AI medical notes